Join to View Full Profile
La Jolla Institute and NovoNordiskSeattle, WA 98101
Phone+1 205-595-1012
Dr. Von Herrath is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Publications & Presentations
PubMed
- 4 citationsPeripheral autoreactive CD8 T-cell frequencies are too variable to be a reliable predictor of disease progression of human type 1 diabetes.Johnna D. Wesley, Susanne Pfeiffer, Darius A. Schneider, David Friedrich, Nikole Perdue
Clinical & Translational Immunology. 2021-01-01 - 1 citationsCorona Pandemic: Assisted Isolation and Care to Protect Vulnerable Populations May Allow Us to Shorten the Universal Lock-Down and Gradually Re-open SocietyJohnny Ludvigsson, Matthias von Herrath, Roberto Mallone, Karsten Buschard, Corrado M. Cilio
Frontiers in Public Health. 2020-09-30 - 10 citationsHuman herpesvirus-6 is present at higher levels in the pancreatic tissues of donors with type 1 diabetesSomayeh Sabouri, Mehdi A. Benkahla, William B. Kiosses, Teresa Rodriguez-Calvo, Jose Zapardiel-Gonzalo
Journal of Autoimmunity. 2020-02-01
Grant Support
- Specificity Of CD8 Cells In Islets From Type 1 Diabetes PatientsNational Institute Of Allergy And Infectious Diseases2011–2012
- Treg Stability In Viral Infection And AutoimmunityNational Institute Of Allergy And Infectious Diseases2010–2011
- Achieving Therapeutic Antigent-Specific Tolerance In Type 1 DiabetesNational Institute Of Diabetes And Digestive And Kidney Diseases2006–2011
- How Il-10r Blockade Can Resolve Persistent Viral InfectionsNational Institute Of Allergy And Infectious Diseases2007–2010
- Faseb Summer Conference On 'Autoimmunity'National Institute Of Allergy And Infectious Diseases2008–2009
- CXCR3 Chemokines In Type I DiabetesNational Institute Of Diabetes And Digestive And Kidney Diseases2004–2009
- Viruses And Autoimmunity PoiNational Institute Of Allergy And Infectious Diseases2004–2009
- How DO Viral Infections Induce AND/OR Enhance AutoimmunityNational Institute Of Allergy And Infectious Diseases2004–2008
- Core--Tetramer CoreNational Institute Of Allergy And Infectious Diseases2004–2008
- Visualization Of Pancreatic T Cell Trafficking During Diabetes DevelopmentNational Center For Research Resources2006–2007
- Role Of A Non-Tolerant Autoantigen In AutoimmunityNational Institute Of Allergy And Infectious Diseases2003–2007
- Animal Models In Type 1 Diabetes And Multiple SclerosisNational Institute Of Diabetes And Digestive And Kidney Diseases2006
- DNA Vaccination &Regulatory Cells In Type I DiabetesNational Institute Of Diabetes And Digestive And Kidney Diseases2003–2006
- Immune Tolerance Induction By Apoptotic BodiesNational Institute Of Allergy And Infectious Diseases2005
- How Does Blockade Of CD40/CD40L Prevent Autoimmunity?National Institute Of Allergy And Infectious Diseases2001–2005
- Use Of Regulatory APCS To Induce/Maintain ToleranceNational Institute Of Allergy And Infectious Diseases2001–2002
- CTB And Autoantigens--T1d Prevention After Oral FeedingNational Institute Of Allergy And Infectious Diseases2001–2002
- Effects Of Aging On The Development And Treatment Of Autoimmune DiabetesNational Institute On Aging1999–2002
- Pathogenesis And Treatment Of Autoimmune DiabetesNational Institute Of Diabetes And Digestive And Kidney Diseases2001
- Regulation And Immunotherapy Of IDDMNational Institute Of Allergy And Infectious Diseases1998–2000
- Pathogenesis And Treatment Of Autoimmune DiabetesNational Institute Of Diabetes And Digestive And Kidney Diseases1996–2000
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
